A three-dimensional laser optoacoustic imaging system was developed, which combines the advantages of optical
spectroscopy and high resolution ultrasonic detection, to produce high contrast maps of optical absorbance in tissues.
This system was tested in a nude mouse model of breast cancer and produced tissue images of tumors and vasculature.
The imaging can utilize either optical properties of hemoglobin and oxyhemoglobin, which are the main endogenous
tissue chromophores in the red and near-infrared spectral ranges, or exogenous contrast agent based on gold nanorods.
Visualization of tissue molecules targeted by the contrast agent provides molecular information. Visulization of blood at
multiple colors of light provides functional information on blood concentration and oxygen saturation. Optoacoustic
imaging, using two or more laser illumination wavelengths, permits an assessment of the angiogenesis-related
microvasculature, and thereby, an evaluation of the tumor stage and its metastatic potential.
The optoacoustic imaging system was also used to generate molecular images of the malignancy-related receptors
induced by the xenografts of BT474 mammary adenocarcinoma cells in nude mice. The development of the latter images
was facilitated by the use of an optoacoustic contrast agent that utilizes gold nanorods conjugated to monoclonal
antibody raised against HER2/neu antigens. These nanorods possess a very strong optical absorption peak that can be
tuned in the near-infrared by changing their aspect ratio. The effective conversion of the optical energy into heat by the
gold nanorods, followed by the thermal expansion of the surrounding water, makes these nanoparticles an effective
optoacoustic contrast agent. Optical scattering methods and x-ray tomography may also benefit from the application of
this contrast agent. Administration of the gold nanorod bioconjugates to mice resulted in an enhanced contrast of breast
tumors relative the background of normal tissues in the nude mouse model. The combination of this novel contrast agent
and optoacoustic imaging has the potential to become a useful imaging modality, for preclinical research in murine
models of cancer and other human diseases.
We have designed, fabricated and tested a new laser optoacoustic imaging system (LOIS-64/16) for quantitative
optoacoustic tomography of breast cancer. The system was designed to create a single slice of an optoacoustic image of
the breast with 64 ultrawide band acoustic transducers. Other 16 transducers on the back of the acoustic probe were used
to reconstruct the light distribution inside the breast. The system resolution was at least 0.5 mm for high-aspect-ratio
objects. Maximum system sensitivity was 4.8 mV/Pa and the RMS noise of 3.1 mV, which allowed imaging of small
(less than 1 cm) tumors at depths over 3 cm. The directivity of the optoacoustic transducers used in LOIS-64/16 assured
that the signal detection was better than 70% of the maximum for about 75% of the imaging slice and reduced quickly
for signals coming from out of the imaging slice. Implemented signal processing allowed significant reduction of the
low-frequency acoustic noise and localizing the small OA signals. The system was able to differentiate phantoms
mimicking tumors and malformations visualized in clinics based on the contrast and morphology of their images
obtained at 1064 nm and 757 nm.
Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks.
You are receiving this notice because your organization may not have SPIE eBooks access.*
*Shibboleth/Open Athens users─please
sign in
to access your institution's subscriptions.
To obtain this item, you may purchase the complete book in print or electronic format on
SPIE.org.
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.